A Phase 3, Long-Term Safety Study of Subcutaneous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME -Anemia Management With Epoetin

NCT01628120 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
170
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer